Skip to main content
    P

    Painreform Ltd (PRFX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.83
    +0.01 (+1.54%)

    Market Cap: $2.87M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(13/20)
    Avg Surprise
    +3.76%
    Streak
    2 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Jul 2
    		$N/AN/AN/ABeat-
    Mar 26
    Reported Apr 6
    		$N/AN/AN/ABeat-
    Sep 25
    Reported Oct 1
    		$0.00$0.00N/ABeat+100.0%
    Jun 25
    Reported Aug 29
    		$-1.09$0.00N/AMiss+97.7%
    Mar 25
    Reported Apr 4
    		$-2.32N/A+69.79%Beat+99.3%
    Dec 24
    Reported Mar 31
    		$-2.32N/A+69.79%Beat+25.4%
    Sep 24
    Reported Nov 19
    		$-18.96$-4.74-300.00%Miss-132.9%
    Jun 24
    Reported Aug 15
    		$-48.00N/A+61.54%Beat+79.2%
    Mar 24
    Reported May 15
    		$-326.40$-288.00-13.33%Miss-148263.6%
    Dec 23
    Reported Feb 29
    		$-3.11$-1.49-108.72%Miss+99.1%
    Sep 23
    Reported Nov 15
    		$57.60N/A+134.29%Beat+124.0%
    Jun 23
    Reported Aug 10
    		$-230.40$-300.00+23.20%Beat-12.9%
    Mar 23
    Reported May 15
    		$-0.22$-0.32+31.25%Beat+99.9%
    Dec 22
    Reported Mar 16
    		$-348.00$-180.00-93.33%Miss-204605.9%
    Sep 22
    Reported Nov 15
    		$-240.00$-204.00-17.65%Miss-11.1%
    Jun 22
    Reported Aug 15
    		$-204.00$-192.00-6.25%Miss-6.3%
    Mar 22
    Reported May 16
    		$-192.00N/A+71.43%Beat+30.4%
    Dec 21
    Reported Mar 17
    		$-0.17N/A+69.09%Beat-
    Sep 21
    Reported Nov 15
    		$-216.00N/A+58.14%Beat-79900.0%
    Jun 21
    Reported Aug 16
    		$-192.00N/A+68.63%Beat+52.9%
    Mar 21
    Reported May 13
    		$-276.00N/A+58.93%Beat-131328.6%
    Dec 20
    Reported Mar 18
    		$0.00N/A+100.00%Beat+100.0%
    Sep 20
    Reported Dec 2
    		$-0.27N/A+98.33%Beat+78.3%
    Jun 20
    Reported Sep 2
    		$-408.00$-102.00-300.00%Miss-32708.0%
    Mar 20
    Reported Jun 30
    		$-0.21$0.00N/AMiss+75.2%
    Dec 19
    Reported Feb 3
    		$-0.10$0.00N/AMiss+88.2%
    Sep 19
    Reported Dec 31
    		$-1.24$0.00N/AMiss-51.1%
    Jun 19
    Reported Sep 30
    		$-1.24$0.00N/AMiss-51.1%
    Mar 19
    Reported Jun 29
    		$-0.85$0.00N/AMiss-5.4%
    Dec 18
    Reported Mar 30
    		$-0.85$0.00N/AMiss-5.4%
    Sep 18
    Reported Dec 31
    		$-0.82$0.00N/AMiss-
    Jun 18
    Reported Sep 30
    		$-0.82$0.00N/AMiss-
    Mar 18
    Reported Jun 29
    		$-0.80$0.00N/AMiss-
    Dec 17
    Reported Mar 30
    		$-0.80$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.14xFCF Yield-713.32%
    Profitability
    Profit Margin0.00%Operating Margin-18114.00%
    ROE-45.30%ROIC-56.06%
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio5.07xQuick Ratio5.07x
    Trading Statistics
    Beta1.08Avg Volume338.03K
    52-Week High$7.9552-Week Low$0.81

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.86
    SMA 20$0.92
    SMA 50$0.96
    SMA 200$1.99
    EMA 10$0.86
    EMA 20$0.90
    EMA 50$0.99
    EMA 200$2.27

    MACD

    Line: -0.04Signal: -0.03Hist: -0.01

    ADX

    ADX: 19.8+DI: 22.4-DI: 20.5

    Aroon & PSAR

    Aroon Up16.0
    Aroon Down100.0
    PSAR$1.10

    Bollinger Bands

    Upper Band$1.04
    Lower Band$0.79
    %B Position2694%(Upper)
    Band Width0.16

    RSI (14-Day)

    Neutral
    35.7

    Momentum Oscillators

    Stoch %K5.8
    Stoch %D5.1
    Williams %R-89.8
    ROC (10d)-12.5%
    Momentum-0.12
    CCI (20d)-110.1
    MFI (14d)38.6

    Volatility Measures

    ATR (14d)$0.06(7.4%)
    StdDev (20d)0.06
    Hist Vol45.8%(High)

    Volume Flow

    VWAP$0.83
    OBV371.0M
    AD Line10.5B
    CMF (20d)-0.507

    Volume Metrics

    Avg Vol (20d)53.7K
    Vol Ratio0.7x
    VWMA (20d)$0.94

    Pivot Points

    R3$0.87
    R2$0.85
    R1$0.84
    Pivot Point$0.82
    S1$0.81
    S2$0.79
    S3$0.78

    Advanced Oscillators

    TSI-22.82
    Ultimate Osc23.7
    KST-94.09

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Mar 2025Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total Revenue$7,000$7,000$17,000$8,500N/AN/A$0$0$0$0$0$0
    Cost of Revenue$28,000$28,000$70,000$35,000N/AN/A$4,000$4,000$6,000$3,000$4,000$2,000
    Gross Profit$-21,000$-21,000$-53,000$-26,500N/AN/A$-4,000$-4,000$-6,000$-3,000$-4,000$-2,000
    Operating Expenses$1.25M$1.25M$5.07M$1.35M$1.18M$881,500$7.34M$5.56M$3.56M$1.35M$2.25M$2.42M
    R&D$403,000$403,000$1.14M$429,000$139,000$149,000$6.67M$4.74M$2.75M$589,000$1.25M$1.45M
    SG&A$581,500$581,500$3.01M$547,000$958,500$732,500$680,000$823,000$818,000$763,000$1.01M$962,000
    Operating Income$-1,268,000$-1,268,000$-5,122,000$-1,377,000$-1,184,000$-881,500$-7,345,000$-5,565,000$-3,564,000$-1,352,000$-2,252,000$-2,416,000
    Interest Income$0$0$0$0$0$0$34,000$64,000$101,000$115,000$81,000$109,000
    Interest Expense$200,000$200,000$0$0$0$0$4,000$5,000$3,000$5,000$4,000$4,000
    Income Before Tax$-1,468,000$-1,468,000$-5,014,000$-1,349,000$-1,158,000$-881,000$-7,312,000$-5,506,000$-4,883,000$36,000$-2,181,000$-2,308,000
    Income Tax Expense$3,000$3,000$8,000$4,000$4,000$4,000$-1$0$8,000$-1,388,000$-71,000$-111,000
    Net Income$-1,398,500$-1,398,500$-4,838,000$-1,261,000$-1,158,000$-885,000$-7,312,000$-5,506,000$-4,891,000$36,000$-2,181,000$-2,197,000
    EBITDA$-1,035,500$-1,035,500$-4,240,000$-1,081,000$-1,093,000$-877,500$-7,341,000$-5,561,000$-3,558,000$-1,349,000$-2,248,000$-2,414,000
    EBIT$-1,268,000$-1,268,000$-5,014,000$-1,377,000$-1,184,000$-881,500$-7,345,000$-5,565,000$-3,564,000$-1,352,000$-2,252,000$-2,416,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PRFX

    News

    Prf Technologies Ltd (PRFX-Q) Stock Price and News

    This article provides stock information and recent news for Prf Technologies Ltd (PRFX-Q), a diversified company focused on specialty pharmaceutical therapies and AI-driven energy analytics. Recent headlines indicate...

    The Globe and Mail•10/2/26•Neutral

    PRF Technologies Faces Board Shake-Up Bid from 5.7% Shareholder S.H.N.

    PRF Technologies is facing a board shake-up bid from S.H.N. Financial Investments Ltd., a 5.7% shareholder. S.H.N. has called for a special general meeting to remove most existing directors and appoint its own nominees...

    The Globe and Mail•9/30/26•Bearish

    A holder claiming 5.7% of voting rights requests a vote to remove directors at PRF Technologies (PRFX).

    S.H.N. Financial Investments Ltd., claiming 5.7% of PRF Technologies' voting rights, has requested a special general meeting to remove the company's non-external directors and appoint three of S.H.N.'s own nominees. PRF...

    Stock Titan•9/28/26•Somewhat-Bearish

    S.H.N. Financial Investments Seeks Board Shake-Up at PRF Technologies with 5.716% Stake

    S.H.N. Financial Investments Ltd., holding a 5.716% stake in PRF Technologies Ltd., has initiated an activist push to shake up the company's board. The investment firm sent a letter calling for a special general meeting...

    TradingView•9/24/26•Somewhat-Bearish

    A shareholder wants all but two directors removed at PRF Technologies (PRFX). How large is its stake?

    S.H.N. Financial Investments Ltd., a shareholder holding 5.716% of PRF Technologies (PRFX) ordinary shares, has requested a special general meeting to propose significant changes to the company's board of directors....

    Stock Titan•9/24/26•Somewhat-Bearish

    PRFX Valuation and Fair Value

    P/FCF
    -0.1x
    P/B
    0.1x
    See GNG's fair value

    PRFX Profitability: Margins, ROIC and FCF

    Gross margin
    -307.6%
    Operating margin
    -18114.0%
    Net margin
    0.0%
    ROIC
    -56.1%
    ROE
    -45.3%
    FCF margin
    -18684.8%
    FCF yield
    -713.3%

    PRFX Competitors

    CompanyTicker
    Revelation Biosciences IncREVB
    HCW Biologics IncHCWB
    Bioatla IncBCAB
    INVO Fertility, Inc.IVF
    Onconetix IncONCO
    VivoSim Labs, Inc.VIVS
    Ridgetech, Inc.RDGT
    Nexalin Technology Inc.NXL

    Sector: Healthcare

    PRFX Bull Case vs Bear Case

    Bear case

    • PRFX beat EPS estimates in 37.5% of its last 8 reported quarters.

    PRFX Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -36.8%

    Frequently Asked Questions About PRFX

    Does PRFX pay dividends?

    Painreform Ltd (PRFX) does not currently pay a regular dividend.

    What is PRFX's market cap?

    Painreform Ltd (PRFX) has a market capitalization of $2.87M with a current stock price of $0.83.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In